Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Akorn

Akorn
1948 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
AKRX STOCK SYMBOL
13 INVESTMENTS
$3.75 SHARE PRICE (As of Friday Closing)
Description

Akorn manufactures ophthalmology and dermatology products as well as injectables. In ophthalmology, the firm primarily sells generic and over-the-counter products but has a small branded portfolio that was purchased from Merck. The firm is primarily focused on the United States.

Website
Formerly Known As
Akorn Ophthalmics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 1925 West Field Court
  • Suite 300
  • Lake Forest, IL 60045
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Akorn’s full profile, request a free trial.

Akorn Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.34 - $5.73 $473M $3.66 -$2.87 1.57M 126M

Akorn Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,153,710 969,180 4,499,537 3,367,487
Revenue 673,558 694,018 841,045 1,116,843
EBITDA (279,665) (309,477) 64,045 401,997
Net Income (361,148) (401,909) (24,550) 184,243
Total Assets 1,398,364 1,495,257 1,909,511 1,973,720
Total Debt 863,413 820,411 815,195 809,979
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Akorn Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Akorn‘s full profile, request access.

Request full access to PitchBook

Akorn Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lannett Company Formerly PE-Backed Philadelphia, PA 0000 00000 000000000 00000
000000 00000000000 Formerly PE-Backed Bridgewater, NJ 0000 00.000 000000 - 000 00.000
0000000 0000000 Corporation Dublin, Ireland 00000 000000&0
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
00000 Corporation Hatfield, United Kingdom 00000 00.00 000000&0 00.00
To view this company’s complete list of competitors, request access »

Akorn Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 02-Jan-2015 000000000000000000 000.00 Therapeutic Devices
0000000 30-Sep-2014 000000000000000000 0000 Pharmaceuticals 00000 000
0000000000 12-Aug-2014 000000000000000000 00000 Pharmaceuticals 00000 000
00-0000 000000000 17-Apr-2014 000000000000000000 00000 Pharmaceuticals 00000 000
BETIMOL 09-Jan-2014 Corporate Asset Purchase Pharmaceuticals 00000 000
To view this company’s complete investment and acquisition history, request access »

Akorn Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000000000 11-Aug-2011 00000 00000 00 000 Completed
  • 4 buyers
To view this company’s complete exits history, request access »

Akorn Subsidiaries (1)

Company Name Industry Location Founded
00-0000 000000000 Pharmaceuticals Amityville, NY 0000
To view this company’s complete subsidiary history, request access »

Akorn Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Akorn‘s full profile, request access.

Request full access to PitchBook

Akorn Executive Team (12)

Name Title Board
Seat
Contact
Info
Michael Stehn Senior Vice President, Operations
Douglas Boothe Chief Executive Officer & Board Member
Duane Portwood Chief Financial Officer & Executive Vice President
Gregory Lawless Chief Human Resources Officer & Executive Vice President
Jennifer Bowles Senior Vice President, Investor Relations

7 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Akorn Board Members (5)

Name Representing Role Since Contact
Info
00000000 000000 00.0 Self Board Member 000 0000
0000000 000000 Akorn Chief Executive Officer & Board Member 000 0000
0000000 0000000000 Self Board Member 000 0000
00000 0000000 Self Board Member 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »